{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:11:00Z","timestamp":1793214660383,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00592-019-01357-y","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T06:37:28Z","timestamp":1557815848000},"page":"1141-1147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["TRActional DIabetic reTInal detachment surgery with co-adjuvant intravitreal dexamethasONe implant: the TRADITION STUDY"],"prefix":"10.1007","volume":"56","author":[{"name":"for the International Retina Group (IRG)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2257-9108","authenticated-orcid":false,"given":"Matias","family":"Iglicki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinah","family":"Zur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Henry","family":"Gabrielle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Lupidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matus","family":"Rehak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafer","family":"Cebeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dua","family":"Masarwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulamit","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adiel","family":"Barak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Loewenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,14]]},"reference":[{"key":"1357_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","volume":"103","author":"L Guariguata","year":"2014","unstructured":"Guariguata L, Whiting DR, Hambleton I et al (2014) Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 103:137\u2013149","journal-title":"Diabetes Res Clin Pract"},{"key":"1357_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.mpmed.2014.10.009","volume":"43","author":"DA Antonetti","year":"2015","unstructured":"Antonetti DA, Klein R, Gardner TW (2015) Diabetic retinopathy. Med (Baltim) 43:13\u201319","journal-title":"Med (Baltim)"},{"key":"1357_CR3","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.2147\/OPTH.S90577","volume":"9","author":"A Sternfeld","year":"2015","unstructured":"Sternfeld A, Axer-Siegel R, Stiebel-Kalish H et al (2015) Advantages of diabetic tractional retinal detachment repair. Clin Ophthalmol 9:1989\u20131994","journal-title":"Clin Ophthalmol"},{"key":"1357_CR4","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/eye.2015.126","volume":"29","author":"MS Dikopf","year":"2015","unstructured":"Dikopf MS, Patel KH, Setlur VJ, Lim JI (2015) Surgical outcomes of 25-gauge pars plana vitrectomy for diabetic tractional retinal detachment. Eye 29:1213\u20131219","journal-title":"Eye"},{"key":"1357_CR5","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1097\/IAE.0000000000001793","volume":"38","author":"PP Storey","year":"2017","unstructured":"Storey PP, Ter-Zakarian A, Philander SA et al (2017) Visual and anatomical outcomes after diabetic traction and traction-rhegmatogenous retinal detachment repair. Retina 38:1913\u20131919","journal-title":"Retina"},{"key":"1357_CR6","doi-asserted-by":"publisher","first-page":"S134","DOI":"10.1097\/IAE.0000000000002093","volume":"38","author":"CM Shroff","year":"2018","unstructured":"Shroff CM, Gupta C, Shroff D et al (2018) Bimanual microincision vitreous surgery for severe proliferative diabetic retinopathy: outcome in more than 300 eyes. Retina 38:S134\u2013S145","journal-title":"Retina"},{"key":"1357_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/08820538.2016.1228397","volume":"32","author":"H El Rami","year":"2017","unstructured":"El Rami H, Barham R, Sun JK, Silva PS (2017) Evidence-based treatment of diabetic retinopathy. Semin Ophthalmol 32:67\u201374","journal-title":"Semin Ophthalmol"},{"key":"1357_CR8","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","volume":"331","author":"LP Aiello","year":"1994","unstructured":"Aiello LP, Avery RL, Arrigg PG et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480\u20131487","journal-title":"N Engl J Med"},{"key":"1357_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1167\/iovs.17-21769","volume":"58","author":"S Vujosevic","year":"2017","unstructured":"Vujosevic S, Sim\u00f3 R (2017) Local and systemic inflammatory biomarkers of diabetic retinopathy: an integrative approach. Invest Ophthalmol Vis Sci 58:68\u201375. \n                    https:\/\/doi.org\/10.1167\/iovs.17","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1357_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00417-004-0950-7","volume":"243","author":"H Funatsu","year":"2005","unstructured":"Funatsu H, Yamashita H, Noma H et al (2005) Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefe\u2019s Arch Clin Exp Ophthalmol 243:3\u20138","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"1357_CR11","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.2337\/db10-0110","volume":"59","author":"ML Schwartzman","year":"2010","unstructured":"Schwartzman ML, Iserovich P, Gotlinger K et al (2010) Profile of lipid and protein autacoids in diabetic vitreous correlates with the progression of diabetic retinopathy. Diabetes 59:1780\u20131788. \n                    https:\/\/doi.org\/10.2337\/db10-0110","journal-title":"Diabetes"},{"key":"1357_CR12","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1210\/jc.2008-2534","volume":"94","author":"RB Goldberg","year":"2009","unstructured":"Goldberg RB (2009) Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 94:3171\u20133182","journal-title":"J Clin Endocrinol Metab"},{"key":"1357_CR13","first-page":"935301","volume":"2013","author":"R dell\u2019Omo","year":"2013","unstructured":"dell\u2019Omo R, Semeraro F, Bamonte G et al (2013) Vitreous mediators in retinal hypoxic diseases. Mediat Inflamm 2013:935301","journal-title":"Mediat Inflamm"},{"key":"1357_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.preteyeres.2011.05.002","volume":"30","author":"J Tang","year":"2011","unstructured":"Tang J, Kern TS (2011) Inflammation in diabetic retinopathy. Prog Retin Eye Res 30:343\u2013358","journal-title":"Prog Retin Eye Res"},{"key":"1357_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-018-1117-z","author":"M Iglicki","year":"2018","unstructured":"Iglicki M, Zur D, Busch C et al (2018) Progression of diabetic retinopathy severity after treatment with dexamethasone implant: a 24-month cohort study the \u2018DR-Pro-DEX Study\u2019. Acta Diabetol. \n                    https:\/\/doi.org\/10.1007\/s00592-018-1117-z","journal-title":"Acta Diabetol"},{"key":"1357_CR16","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1080\/10717544.2018.1440664","volume":"25","author":"SW Moon","year":"2018","unstructured":"Moon SW, Sun Y, Warther D et al (2018) New model of proliferative vitreoretinopathy in rabbit for drug delivery and pharmacodynamic studies. Drug Deliv 25:600\u2013610. \n                    https:\/\/doi.org\/10.1080\/10717544.2018.1440664","journal-title":"Drug Deliv"},{"key":"1357_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0161-6420(83)34588-7","volume":"90","author":"G Hilton","year":"1983","unstructured":"Hilton G, Machemer R, Michels R, Okun E, Schepens C, Schwartz A (1983) The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 90:121\u2013125","journal-title":"Ophthalmology"},{"key":"1357_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2323897","author":"S Deuchler","year":"2017","unstructured":"Deuchler S, Ackermann H, Singh P et al (2017) Key factors to improve the outcome of retinal reattachment surgery in proliferative vitreoretinopathy and proliferative diabetic retinopathy. J Ophthalmol. \n                    https:\/\/doi.org\/10.1155\/2017\/2323897","journal-title":"J Ophthalmol"},{"key":"1357_CR19","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1177\/112067210701700423","volume":"17","author":"F Goezinne","year":"2007","unstructured":"Goezinne F, La Heij EC, Berendschot TTJM et al (2007) Risk factors for redetachment and worse visual outcome after silicone oil removal in eyes with complicated retinal detachment. Eur J Ophthalmol 17:627\u2013637","journal-title":"Eur J Ophthalmol"},{"key":"1357_CR20","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1001\/archopht.123.4.473","volume":"123","author":"IU Scott","year":"2005","unstructured":"Scott IU, Flynn HW, Murray TG et al (2005) Outcomes of complex retinal detachment repair using 1000- vs 5000-centistoke silicone oil. Arch Ophthalmol 123:473\u2013478. \n                    https:\/\/doi.org\/10.1001\/archopht.123.4.473","journal-title":"Arch Ophthalmol"},{"key":"1357_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2415-6-21","volume":"6","author":"M Soheilian","year":"2006","unstructured":"Soheilian M, Mazareei M, Mohammadpour M, Rahmani B (2006) Comparison of silicon oil removal with various viscosities after complex retinal detachment surgery. BMC Ophthalmol 6:1\u20136. \n                    https:\/\/doi.org\/10.1186\/1471-2415-6-21","journal-title":"BMC Ophthalmol"},{"key":"1357_CR22","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1097\/IAE.0b013e3181853d3c","volume":"28","author":"T Altan","year":"2008","unstructured":"Altan T, Acar N, Kapran Z et al (2008) Transconjunctival 25-gauge sutureless vitrectomy and silicone oil injection in diabetic tractional retinal detachment. Retina 28:1201\u20131206","journal-title":"Retina"},{"key":"1357_CR23","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1167\/iovs.15-16526","volume":"56","author":"H Hou","year":"2015","unstructured":"Hou H, Huffman K, Rios S et al (2015) A novel approach of daunorubicin application on formation of proliferative retinopathy using a porous silicon controlled delivery system: pharmacodynamics. Invest Ophthalmol Vis Sci 56:2755\u20132763","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1357_CR24","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s13063-018-2761-x","volume":"19","author":"F Schaub","year":"2018","unstructured":"Schaub F, Hoerster R, Schiller P et al (2018) Prophylactic intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy in high-risk patients with retinal detachment: study protocol for a randomized controlled trial. Trials 19:384","journal-title":"Trials"},{"key":"1357_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2018-312839","author":"NJS London","year":"2018","unstructured":"London NJS, Kaiser RS, Khan MA et al (2018) Determining the effect of low-dose isotretinoin on proliferative vitreoretinopathy: the DELIVER trial. Br J Ophthalmol. \n                    https:\/\/doi.org\/10.1136\/bjophthalmol-2018-312839","journal-title":"Br J Ophthalmol"},{"key":"1357_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/tvst.6.4.5","volume":"6","author":"H Kaneko","year":"2017","unstructured":"Kaneko H, Terasaki H (2017) Biological Involvement of microRNAs in proliferative vitreoretinopathy. Transl Vis Sci Technol 6:5","journal-title":"Transl Vis Sci Technol"},{"key":"1357_CR27","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1177\/1932296816628546","volume":"10","author":"M Bhaskaranand","year":"2016","unstructured":"Bhaskaranand M, Ramachandra C, Bhat S et al (2016) Automated diabetic retinopathy screening and monitoring using retinal fundus image analysis. J Diabetes Sci Technol 10:254\u2013261. \n                    https:\/\/doi.org\/10.1177\/1932296816628546","journal-title":"J Diabetes Sci Technol"},{"key":"1357_CR28","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ophtha.2017.01.021","volume":"124","author":"PJ Banerjee","year":"2017","unstructured":"Banerjee PJ, Quartilho A, Bunce C et al (2017) Slow-release dexamethasone in proliferative vitreoretinopathy: a prospective, randomized controlled clinical trial. Ophthalmology 124:757\u2013767","journal-title":"Ophthalmology"},{"key":"1357_CR29","doi-asserted-by":"publisher","first-page":"815937","DOI":"10.1155\/2012\/815937","volume":"2012","author":"SN Moysidis","year":"2012","unstructured":"Moysidis SN, Thanos A, Vavvas DG (2012) Mechanisms of inflammation in proliferative vitreoretinopathy: from bench to bedside. Mediat Inflamm 2012:815937","journal-title":"Mediat Inflamm"},{"key":"1357_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.preteyeres.2015.07.005","volume":"51","author":"JC Pastor","year":"2016","unstructured":"Pastor JC, Rojas J, Pastor-Idoate S et al (2016) Proliferative vitreoretinopathy: a new concept of disease pathogenesis and practical consequences. Prog Retin Eye Res 51:125\u2013155","journal-title":"Prog Retin Eye Res"},{"key":"1357_CR31","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1097\/IAE.0b013e3181fe5427","volume":"31","author":"W Chen","year":"2011","unstructured":"Chen W, Chen H, Hou P et al (2011) Midterm results of low-dose intravitreal triamcinolone as adjunctive treatment for proliferative vitreoretinopathy. Retina 31:1137\u20131142","journal-title":"Retina"},{"key":"1357_CR32","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3928\/15428877-20070901-02","volume":"38","author":"RA Cheema","year":"2007","unstructured":"Cheema RA, Peyman GA, Fang T et al (2007) Triamcinolone acetonide as an adjuvant in the surgical treatment of retinal detachment with proliferative vitreoretinopathy. Ophthalmic Surg Lasers Imaging 38:365\u2013370","journal-title":"Ophthalmic Surg Lasers Imaging"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01357-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-019-01357-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01357-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T23:20:34Z","timestamp":1589325634000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-019-01357-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["1357"],"URL":"https:\/\/doi.org\/10.1007\/s00592-019-01357-y","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,14]]},"assertion":[{"value":"27 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Tel Aviv Sourasky Medical Center Institutional Review Board (Helsinki Committee), nr. 0745-18-TLV.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}